---
title: 'Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin
  for chronic kidney disease: a randomised, controlled, phase 2 tr...'
date: '2023-12-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38109916
source: Trending page - PubMed
description: '<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Tuttle+KR&amp;cauthor_id=38109916"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="Katherine R Tuttle">Katherine R Tuttle</a><sup class="affiliation-links"><span
  class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="University
  of Washington, Seattle, WA, USA; Providence Inland Northwest Health, Spokane, WA,
  USA. Electronic address: katherine.tuttle@providence.org." href="https://pubmed.ncbi.nlm.nih.gov/38109916#full-view-a
  ...'
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Tuttle+KR&amp;cauthor_id=38109916" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Katherine R Tuttle">Katherine R Tuttle</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="University of Washington, Seattle, WA, USA; Providence Inland Northwest Health, Spokane, WA, USA. Electronic address: katherine.tuttle@providence.org." href="https://pubmed.ncbi.nlm.nih.gov/38109916#full-view-a ...